Fingerprint
Dive into the research topics of 'Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years
Ivette Maldonado, Manuel Plata, Mauricio Gonzalez, Alfonso Correa, Claudia Nossa, Anna R. Giuliano, Elmar A. Joura, Alex Ferenczy, Brigitte M. Ronnett, Mark H. Stoler, Hao Jin Zhou, Amita Joshi, Rituparna Das, Oliver Bautista, Thomas Group, Alain Luxembourg, Alfred Saah, Ulrike Kirsten Buchwald*
*Corresponding author for this work
- Fundación Santa Fe de Bogotá
- Fundación Cardioinfantil - Instituto de Cardiología
- Instituto Nacional de Cancerología - Colombia
- Clínica del Country
- Cafam University Foundation
- Moffitt Cancer Center
- Medical University of Vienna
- McGill University
- Johns Hopkins University
- University of Virginia
- Merck
- Sun Yat-Sen University
Research output: Contribution to journal › Article › peer-review
16
Citations
(Scopus)